Latest News
New Meds and Tech – Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes
Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta, MD and…
Recent Headlines
Featured Resources
You can now purchase access to the all the Board Review Course materials:
-
- Access to video files that capture the audio recordings of lectures, synchronized to the images of the slides presented.
-
- Full color pdf of all slides plus and any supplemental information from speakers that was not covered during the presentation.
You can watch the videos on your own time - and as many times as you need.
Online Community
Expanding professional networks through dialogue and idea exchange is one of the many benefits this platform has to offer.
Mission Alliance Partners
These organizations share similar missions and values to PES. Learn more about our Mission Alliance Partners, and find out how you can become one.
PLATINUM Mission Alliance Partners
GOLD Mission Alliance Partners
